FDA Drug Recalls

Recalls / Class I

Class ID-0236-2024

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7

Brand name
Americaine
Generic name
Benzocaine
Active ingredient
Benzocaine
Route
Topical
NDC
63736-378
FDA application
M017
Affected lot / code info
Lot # 1A16420, exp. date 01/31/2025

Why it was recalled

Chemical Contamination: presence of benzene

Recalling firm

Firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Manufacturer
Insight Pharmaceuticals LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
660 White Plains Rd Ste 250, N/A, Tarrytown, New York 10591-5171

Distribution

Quantity
34,704 cans
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-12-21
FDA classified
2024-01-17
Posted by FDA
2024-01-24
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0236-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: Americaine · FDA Drug Recalls